+

WO1999049813A1 - Appareil pour ajuster la courbure de la cornee au moyen d'implants corneens multiples amovibles - Google Patents

Appareil pour ajuster la courbure de la cornee au moyen d'implants corneens multiples amovibles Download PDF

Info

Publication number
WO1999049813A1
WO1999049813A1 PCT/US1999/006923 US9906923W WO9949813A1 WO 1999049813 A1 WO1999049813 A1 WO 1999049813A1 US 9906923 W US9906923 W US 9906923W WO 9949813 A1 WO9949813 A1 WO 9949813A1
Authority
WO
WIPO (PCT)
Prior art keywords
implant
corneal
strands
strand
corneal implant
Prior art date
Application number
PCT/US1999/006923
Other languages
English (en)
Inventor
Joseph Lee
Stephen Jang
Original Assignee
Microoptix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microoptix Llc filed Critical Microoptix Llc
Priority to AU33719/99A priority Critical patent/AU3371999A/en
Publication of WO1999049813A1 publication Critical patent/WO1999049813A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/013—Instruments for compensation of ocular refraction ; Instruments for use in cornea removal, for reshaping or performing incisions in the cornea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/147—Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants

Definitions

  • This invention relates to a method and apparatus for adjusting corneal curvature and, more particularly, to an implantable device adapted for insertion into the peripheral cornea of an eye and which may be modified in the amount of volume of peripheral corneal tissue it displaces at the time of insertion and at post-operative times to correct refractive error by removing solid material from the implanted device.
  • Ametropia an undesirable refractive condition of the eye, has three main subdivisions: myopia, hyperopia, and astigmatism.
  • myopia by far the most common type of ametropia.
  • the parallel light rays 1 which enter the eye as shown in FIG. 1(c) come to a focus F3 in front of the retina 2.
  • hyperopia the rays of light 1 come to a focus F2 behind the retina 2 as shown in FIG. 1(b).
  • astigmatism in which condition the various foci may all lie before the retina; all lie behind the retina; or partly before and partly behind the retina.
  • Ametropia is usually corrected by glasses or contact lenses. However, these refractive disorders may also be corrected by surgery. Refractive eye surgery is defined as that surgery on the eye that acts to change the light-bending qualities of the eye. More common current refractive procedures include radial keratotomy, as described in U.S. Pat. 4,815.463 and 4,688,570 and also laser ablation of corneal stroma, described in U.S. Pat. 4,941,093. Various other surgical methods for the correction of refractive disorders have been tried including thermokeratoplasty for the treatment of hyperopia, epikeratoplasty to correct severe hyperopia, and keratomileusis, which can steepen or flatten the central cornea.
  • Keratomileusis was introduced by Barraquer of Colombia in 1961 and essentially involves grinding a corneal button into an appropriate shape to correct the refractive error and replacing the reshaped corneal button. Some of the more common keratorefractive procedures are discussed below; none of which have all the characteristics of an ideal keratorefractive procedure.
  • the disadvantages of corneal refractive surgery include limited predictability, lack of reversibility, corneal destabilization, optical zone fibrosis, postoperative discomfort, and visual symptoms such as glare, halos, and starbursts.
  • RK should be considered a two-stage surgery, with the initial surgery to achieve the "ball-park" correction, followed by an enhancement procedure to adjust or titrate the result near the desired outcome for an individual eye. It was felt that because of individual variability which may lead to an under or over-correction in the individual different from that predicted by the nomogram, attempting to fully correct the refractive error in one surgery could lead to over-correction in a significant number of surgeries, resulting in hyperopia which is much more difficult to correct. Unfortunately, the second-stage surgery is even less predictable than the initial procedure.
  • a patient may be corrected with resultant slight hyperopia and yet have 20/20 vision because of the ability of the lens to accommodate.
  • stromal scar formation which manifests as stromal haze and possible decrease in contrast sensitivity by the patient.
  • This corneal stromal opacification is variously referred to as fibrosis, scarring, or haze which is associated with reduced visual acuity and contrast sensitivity, regression of the refractive effect, and poor night vision.
  • Predictability with PRK is an issue, as with RK.
  • Most published results of outcome after PRK treatment for myopia show 80-94% of eyes obtaining uncorrected visual acuity of 20/40 or better while the percentage of patients achieving 20/20 is significantly less.
  • the criteria for an ideal refractive procedure include adjustability, predictability/efficacy, maintenance of quality of vision, reversibility, simplicity, stability, safety, and low cost. Each of these factors are reviewed: 1. Adjustability. Because of corneal wound healing and the delicate corneal curvature changes required to achieve 20/20 uncorrected vision, it is unlikely that any refractive procedure will achieve 20/20 vision with a single procedure. The refractive literature is abundant with comments and opinions describing the need for an adjustable procedure. PRK attempts adjustments or "enhancements by repeating the same process — removal of epithelium and re-ablation. If there was variability in the initial PRK procedure, it is unlikely that the same procedure will be able to "fine-tune" the refractive outcome.
  • PRK ablates the central cornea and corneal haze is an issue as evidenced by a small percentage of patients with a decrease in best-corrected visual acuity.
  • Visually comprising complications include haze and scarring, halo effect, decreased contrast sensitivity, and decentration of ablation. Any procedure that operates on the central cornea will result in decreasing the best-corrected visual acuity in at least a small percentage of patients.
  • a reversible procedure such as corneal rings
  • a reversible procedure such as implantable intraocular lenses
  • Many potential patients have not had vision correction surgery because of its irreversibility.
  • Photorefractive keratectomy offers the possibility of solving one of the major causes of poor predictability by reducing the surgical variability of the procedure.
  • a major unresolved issue is how the second nemesis that causes poor predictability, corneal wound healing, will affect the results of PRK.
  • Typical refractive surgery studies, including RK and PRK report the post-operative refraction in terms of the percentage of patients achieving +/- 1 diopter of emmetropia. Approximately 80 - 90% of patients achieve this range. However, only approximately 7
  • the goal in refractive surgery is to achieve emmetropia.
  • On the myopic side a patient can be -0.30 D or less and still see 20/20 uncorrected.
  • the issue is slightly more complex on the hyperopic side due to the availability of lens accommodation.
  • the average 30 year-old has a total of 7 diopters of accommodation available to him and can easily supply several diopters from his "storehouse" of reserve. Reading a book or newspaper at arms-length (40 cm) requires 2.5 diopters of accommodation for the emmetrope.
  • the modern refractive surgeon has several weapons in his armamentarium to choose from in attacking myopia.
  • the refractive surgeon knows the limitations of his options. It is understood that RK is moderately predictable, adjustable only towards hyperopia, and irreversible. PRK is also moderately predictable, adjustable only towards hyperopia with the caveat that there is some regression towards myopia, but also essentially irreversible. On cardinal rule of refractive surgery is to avoid overcorrection because the options for a patient who is over-corrected to hyperopia are much more limited.
  • Zhivotovskii D. S., USSR Patent No. 3,887,846, describes an alloplastic, flat, geometrically regular, annular ring for intracorneal implantation of an inside diameter that does not exceed the diameter of the pupil. Refractive correction is accomplished primarily by making the radius of curvature of the surface of the ring larger than the radius of curvature of the surface of a recipient's cornea in order to achieve flattening of the central area of the cornea. Surgical procedures for inserting the ring are not described.
  • A. B. Reynolds (U.S. Patent No. 4,452,235) describes and claims a keratorefractive technique involving a method and apparatus for changing the shape of the optical zone of the cornea to correct refractive error.
  • His method comprises inserting one end of a split ring shaped dissecting member into the stroma of the cornea, moving the member in an arcuate path around the cornea, releasably attaching one end of a split ring shaped adjusting member to one end of the dissecting member, reversibly moving the dissecting member about the path, and thereby pulling the adjusting member about the circular path, made by the dissecting member, withdrawing the dissecting member, adjusting the ends of the split-ring shaped adjusting member relative to one another to thereby adjust the ring diameter to change the diameter and shape of the cornea and fixedly attaching the ring's ends by gluing to maintain the desired topographical shape of the cornea.
  • the first problem is concerned with the ability to predetermine the shape and size of an implant that will lead to a certain refractive outcome.
  • RK or PRK retrospective studies have been performed that led to the development of nomograms which predict that a certain depth cut or a certain ablation amount will result in a predictable amount of correction.
  • nomograms will be developed that can be used to predict a given refractive correction for a given thickness or size of the ring.
  • these nomograms can never fully account for individual variability in the response to a given keratorefractive procedure. 10
  • the refractive outcome also depends on the stability of the refractive correction achieved after surgery.
  • the advantage of the ring would be the stability of the refractive outcome achieved because of a presumed minimal wound healing response. This decreases the variability of the long-term refractive outcome but still does not address the problems posed in the first problem area, ⁇ the inherent individual variability, in that while the outcome may be stable, it may very well be an inadequate refractive outcome that is stable.
  • Simon in U.S. Pat. No. 5,090,955 describes a surgical technique that allows for modification of the corneal curvature by inter-lamellar injection of a synthetic gel at the corneal periphery while sparing the optical zone. He does discuss an infra-operative removal of gel to decrease the volume displaced and thus adjust the final curvature of the central corneal region.
  • Siepser (U.S. Pat. No. 4,976,719) describes another ring-type device to either flatten or steepen the curvature of the cornea by using a retainer ring composed of a single surgical wire creating a ring of forces which are selectively adjustable to thereby permit selective change of the curvature of the cornea, -- the adjustable means comprising a turnbuckle attached to the wire.
  • the cornea like most soft tissues, is nonlinear, viscoelastic, nonhomogeneous, and can exhibit large strains under physiologic conditions.
  • the whole eye is geometrically extremely complex and the biomechanics technique capable of systematically modeling this reality is the finite element method which assumes small strains (a measure of deformity), homogeneity, and linear elastic behavior. Two simple mechanisms will be briefly described. 11
  • a constricting or expanding implant is likely to cause a less stable refractive outcome because the inward or outward forces of the implant against the corneal stroma may gradually cause further lamellar dissection and dissipation of the forces. A more consistent outcome is likely to be achieved with varying the volume displaced in the peripheral cornea as described by Simon.
  • the present invention concerns the use of an adjustable intrastromal device adapted for implantation in the cornea and formed of at least three ring-shaped and flexible elongated 13
  • the strands have a radial cross-sectional shape that is circular or oval. These strands are implanted in the cornea in surrounding relation to the optical zone of the cornea. The strands maintain their proximity to one another by the presence of periodic bands, which encircle the strands. These bands are spaced apart from each other such that there are a total of at least three bands surrounding the strands. The corneal curvature is then adjusted by complete removal of one or more strands thus modifying the volume of peripheral corneal tissue displaced in a discrete fashion and resulting in steepening of the central corneal curvature and a myopic shift.
  • the apparatus of the invention is an adjustable implantable device and adapted to be inserted into the interlamellar space of the corneal stroma for the purpose of correcting refractive error.
  • the peripheral corneal volume displaced by the device is easily discretely modified on multiple occasions following the initial surgery of implantation and thus allows for adjustment of the refractive outcome at a later date without necessitating the complete removal of the implanted device.
  • FIG. 1(a) is a schematic representation of an eye demonstrating light rays focusing on the retina
  • FIG. 1(b) is a schematic representation of a hyperopic eye
  • FIG. 1(c) is a schematic representation of a myopic eye
  • FIG. 2(a) is a schematic representation of a rope between two fixed points
  • FIG. 2(b) is a schematic representation which shows the rope of FIG. 2(a) with the force3 of a weight applied to the rope between its midpoint and one of the fixed points; 14
  • FIG. 3(a) is a schematic representation of the cornea of an eye wherein the cornea is fixedly attached at diametrically opposed points on the surrounding limbus;
  • FIG. 3(b) is an illustration similar to FIG. 3(a) but showing the curvature effects produced on the cornea because of the presence of an intrastromal support implant in the cornea
  • FIG. 3(c) is an illustration similar to FIG. 3(b) but showing the curvature effects on the cornea following removal of the intrastromal support implant from the cornea
  • FIG. 4(a) is a plan view of the split-ring form of the device of the invention.
  • FIG. 4(b) is a plan view of the arc-segment form of the device of the invention.
  • FIG. 5(a) is a plan view demonstrating bands on the split-ring form of the device of the invention.
  • FIG. 5(b) is a plan view demonstrating bands on the arc-segment form of the device of the invention.
  • FIG. 6(a) is a radial cross-sectional view of the device of the invention within the cornea of the eye
  • FIG. 6(b) is a plan view of the device of the invention within the cornea of the eye
  • FIG. 7(a) is a radial cross-sectional view of the device of the invention within the cornea of the eye illustrating the dimensions of the device;
  • FIG. 7(b) is a radial cross-sectional view similar to FIG. 7(b) demonstrating smaller dimensions of the device following removal of several strands;
  • FIG. 8(a) is a perspective view of a hollow instrument for insertion of the device of the invention;
  • FIG. 8(b) is a plan view of the instrument of FIG. 8(a);
  • FIG. 8(c) is a perspective view of a cut through the tube portion of the instrument of FIG.
  • FIG. 8(d) is an expanded view of the cut portion from FIG. 8(c), demonstrating the hollow nature of the instrument;
  • FIG. 9(a) is a similar view to FIG. 8(a); 15
  • FIG. 9(b) is a view of the instrument in FIG. 9(a) containing the device of the invention in the process of insertion within the cornea of an eye;
  • FIG. 10(a) is a perspective view of the surgical instrument of FIG. 8(a) with a leading segment attached to the leading end of the instrument
  • FIG. 10(b) is a plan view of the surgical instrument of FIG. 10(a) with a leading segment positioned at the leading end of the instrument;
  • FIG. 11(a) is a plan view of the surgical instrument of FIG. 10(a) almost completely inserted into the intrastromal annular lamellar channel of the cornea;
  • FIG. 11(b) is a plan view of the instrument of FIG. 11(a) partially removed from the cornea of the eye and the ring device of the invention partially positioned within the lamellar channel of the cornea;
  • FIG. 11(c) is a plan view of FIG. 11(b) after the instrument has been completely removed, the device of the invention in position within the intrastromal annular channel of the cornea, and the leading segment removed from the device of the invention;
  • FIG. 12(a) is a radial cross sectional view of the line l ib — 1 lb from FIG. 11(b) which shows the instrument within the lamellar channel and the ring device of the invention within the instrument;
  • FIG. 12(b) is a radial cross sectional view of the line l ie — l ie from FIG. 11(c) which shows the ring device of the invention within the lamellar channel of the cornea;
  • FIG. 13 is a perspective view of a circular hook instrument for insertion of the device of the invention;
  • FIG. 14(a) is a plan view of the instrument of FIG. 13 partially inserted into the cornea of the eye and the ring device of the invention partially positioned within the lamellar channel of the cornea;
  • FIG. 14(b) is a plan view of FIG. 14(a) after the instrument has been completely withdrawn from the lamellar channel, the ring device of the invention completely positioned within the intrastromal annular channel of the cornea, and the leading segment removed from the device of the invention; 16
  • FIG. 15(a) is a plan view of the ring device of the invention halfway inserted into the cornea using a magnetic instrument to pull the ring device into position within the lamellar channel of the cornea;
  • FIG. 15(b) is a plan view similar to FIG. 15(a) after the ring device of the invention has been completely inserted and the leading segment removed from the device of the invention;
  • FIG. 16 is a perspective view of a radial cross section of a cornea containing the ring device of the invention, at a point where an anterior incision into the cornea has been made to facilitate removal of a strand from the ring device of the invention;
  • FIG. 17(a) is a graph showing the distribution of typical refractive surgery outcomes
  • FIG. 17(b) is a graph showing the expected distribution of refractive surgery outcomes with hyperopic over-correction
  • FIG. 17(c) is a graph showing the expected distribution of the ring device of the invention outcomes following an adjustment procedure
  • FIG. 18(a) is a schematic representation of the cornea of an eye wherein the cornea is fixedly attached at diametrically opposed points on the surrounding limbus;
  • FIG. 18(b) is an illustration similar to FIG. 18(a) but showing the curvature flattening effects produced on the central cornea because of the presence of the ring device of the invention in the peripheral cornea;
  • FIG. 18(c) is an illustration similar to FIG. 18(b) but showing the partially re-steepening effects on the central corneal curvature following removal of two strands from the implanted ring device of the invention.
  • FIG. 4-6 there is shown in FIG. 4-6 the apparatus of the present invention 20.
  • the present invention concerns the use of an adjustable intrastromal device adapted for implantation in the cornea 13 and formed of at least three ring-shaped and flexible elongated strand-like filaments 16 of a variable size.
  • the strands 17 are shown in FIG. 4-6.
  • These strands are implanted in the cornea 13 in surrounding relation to the optical zone of the cornea as demonstrated in FIG. 6(b).
  • the device 20 is composed of at least three strands 16 of a bio-compatible plastic or polymer material such as polymethylmethacrylate (PMMA), nylon, polypropylene, polyester, polyimide, or fluoropolymer resins.
  • the strands can be any biocompatible material that is a flexible, filamentous structure and may be constructed from a resilient polymeric substance such as that described above but the preferred material is PMMA. Its composition material may be similar to those materials used in producing foldable or deformable intraocular lenses such as a silicone polymer, urethane polymer, acrylic polymer, or hydrogel.
  • the strands consist of a flexible material, which is biocompatible, and more specifically, compatible with ocular tissues.
  • the strands may also be composed of a porous polymer material such as a microporous polypropylene material.
  • the strands may be composed of one or more natural or synthetic polymers.
  • An example of a natural polymer that may be used is collagen.
  • the composition material of the strands may be any suitable plastic or polymer material such as that used in producing foldable or deformable lenses, silicone polymers, urethane polymers, acrylic polymers, polyesters, fluoropolymer resins, or materials used in soft contact lenses. It will be understood by those skilled in the art that, among polymers of acrylic esters, those made from acrylate ester monomers tend to have lower glass transition temperatures and to be more flexible than polymers of methacrylate esters.
  • polystyrene foams there are many other suitable polymeric materials, including but not limited to epoxy resins, polyamides, polyacetals, polycarbonates, polyethers/ether ketones, polyolefins, polyurethanes, polyvinylpyrrolidone, natural or synthetic rubbers, polysulfones, copolymers, and combinations of the above.
  • suitable polymeric materials including but not limited to epoxy resins, polyamides, polyacetals, polycarbonates, polyethers/ether ketones, polyolefins, polyurethanes, polyvinylpyrrolidone, natural or synthetic rubbers, polysulfones, copolymers, and combinations of the above.
  • other medical devices composed of materials which be suitable for the shell of this invention include vascular graft tubing, dialysis tubing or membrane, blood oxygenator tubing or membrane, ultrafiltration membrane, intra aortic balloon, catheter, 18
  • suture, soft or hard tissue prosthesis, artificial organ, and lenses for the eye such as contact and intraocular lenses.
  • the surfaces of the strands are smooth and do not have raised or indented areas and do not intermesh with each other. This is important for ease of strand removal at a later date.
  • the surface of the strands may also undergo surface modification by currently known techniques to decrease surface friction relative to each other and to the surrounding stroma in anticipation of possible later strand removal.
  • a key element of this invention is attention to the details that facilitate strand removal from the cornea at a later date, such as surface modification.
  • FIG. 4(a) is shown the device of the invention 20, consisting of at least three strands 16 in an annular configuration with two ends 21.
  • FIG. 4(b) shows segments of strands 22 that are less than 360 degrees.
  • the U.S. Patent, "Adjustable Corneal Arcuate Segments", filed by this author in 1998, is included herein in its entirety by reference. It is anticipated by this author that the various segment shapes and arc lengths described in the "Adjustable Corneal Arcuate Segments" patent can also be applied to the device of the current invention in the treatment of astigmatism, hyperopic astigmatism, myopic astigmatism, and the adjustments thereof.
  • the strands 16 have bands 23 that surround the strands.
  • the purpose of the bands is to maintain the strands 16 in relative proximity to each other such that the radial cross-section of the device, as demonstrated in FIG. 6(a), has a generally oval configuration. It can be seen that strands of a circular radial cross-section do not easily stack on top of each other and will tend to spread apart from each other unless the strands are confined in relative proximity to each other by some means.
  • the bands 23 serve the purpose of confining the strands such that the radial cross-section of the device is generally oval.
  • the strands may be held together in relative proximity to each other by various other means such that following implantation the relative position of the strands to each other does not significantly change.
  • the strands are maintained in their proximity to one another by the presence of periodic bands 23 that 19
  • the encircling bands are positioned such that there are at least three bands for the 360 degrees and typically having 5 to 7 bands equidistant from each other.
  • the bands may be composed of the same material previously described for the strands.
  • the band may also be up to several millimeters in width. The bands are not physically attached to the strands, allowing the strands to be easily removed at a later date. From FIG.
  • the strands 16 are confined in a generally oval shape by the walls 24,25 of the intrastromal annular channel.
  • the walls of the channel may suffice in maintaining the device in a generally oval cross section. If, however, the intrastromal channel is initially made larger than the radial cross-section of the device, the strands of the device will separate from each other and result in a device with a radial cross-section that is a flatter oval.
  • the bands may be useful in this situation to maintain the radial cross-sectional shape of the device until the inner 27 and outer 26 diameters of the channel wall undergo healing and are not easily further delaminated. Because the walls of the channel 24-27 undergo healing and will eventually form itself around the device confining the strands in a generally oval cross-section, it is not essential that the bands be composed of a permanent material. Although bands effectively accomplish their purpose of confining the strands within a certain shape, there are other methods of accomplishing the same goal.
  • the strands may also be maintained in relative proximity to each other such that the radial cross-sectional shape of the device is generally pval, by the use of a biocompatible adhesive.
  • the adhesive is preferably weak and necessarily temporary since it is anticipated that at least a single strand will later be removed.
  • the adhesion is required only until the intrastromal channel walls undergo healing around the implanted device. If a strand is to be later removed, it must not be attached to surrounding strands.
  • Strands 16 having a radial cross-sectional circular or oval cross-sectional shape have the greatest volume relative to its surface area. Thus, these strands also displace the greatest amount of peripheral corneal tissue relative to its area of contact with the corneal stroma- strand interface, thus allowing minimal disturbance of the strand-cornea interface while permitting maximum volume displacement alteration when the strand is later removed. If, as previously described, the strands are of a circular cross-sectional shape, the strands will not easily stack on top of each other but rather separate from each other within the peripheral lamellar corneal channel and result in less effect on the anterior corneal curvature.
  • the collection of strands must be maintained in relative proximity to each other in order for the collection of strands to have a maximal stable refractive effect. For example, using strands with a circular cross-sectional shape, two strands that are stacked on two other strands will have more of a refractive effect than four strands each positioned one next to the other. If the corneal lamellar channel is completely filled with the circular cross-sectional strands, it is unlikely for the strands to shift significantly. However, if the channel cannot be completely filled with the circular cross-sectional strands, the strands will shift and spread apart. Also, because of the manner of strand implantation within the channel, it may be difficult to completely fill the channel with strands.
  • a simple approach to this problem is the implantation of an expandable strand, such as that made of hydrogel, along with the other strands.
  • Hydrogel expands by up to 70% with the absorption of water.
  • the hydrogel strand expands such that all the strands combined completely fill the channel.
  • Strands of the hydrated hydrogel are unlikely to be sufficiently strong to allow strand removal from the implanted cornea in the typical method.
  • the strands composed of stronger materials may be removed from the peripheral cornea in the event of overcorrection. 21
  • the device 20 consists of at least three strands adapted to be implanted into the peripheral stromal cornea.
  • the strands 16 are maintained in relative proximity to each other by the walls 24,25 of the annular corneal channel.
  • the device is of a thickness and geometry such that when implanted it alters the central corneal curvature without intruding into the central optical zone of the cornea and without decreasing the diffusion of nutrients to the central cornea. It is of a size such that it can be readily inserted into the peripheral human cornea.
  • the radial cross section of a strand may be of various geometric shapes. However, the preferred embodiment has a radial cross-sectional shape that is circular or oval.
  • the radial cross-sectional area of the strand can vary in dimension along its length.
  • the device is composed of at least three strands, at least one of which is easily removable from the cornea at a later time.
  • the device may be composed of strands of varying cross-sectional shape, cross-sectional area, and material composition.
  • the advantage of a circular cross-section is that it allows the greatest peripheral corneal tissue volume displacement with the least strand surface area. Decreasing the amount of surface contact between the strand and the cornea allows each strand to be removed at a later time while minimizing the amount of disturbance to the strand-corneal stroma interface thus minimizing the possibility of a potentially unpredictable secondary wound healing response.
  • the range of dimensions of the peripheral corneal volume displacement provided by the strands as shown in FIG. 7(a) include a height of (30) of 0.1-1.0 mm, width (31) of 0.3 to 2.0 mm and an over-all diameter of 4.00 to 11.0 mm.
  • a typical device which is expected to correct myopia by approximately 3 diopters, has a width of 0.85 mm and height of 0.3 mm. The width is 0.85 mm and height is 0.3 mm.
  • a device displacing corneal volume by this amount is expected to correct myopia by approximately 3 diopters.
  • a device displacing greater corneal volume would be required for myopic correction of 4 diopters and a device displacing corneal volume by less than this amount required for myopic correction of 2 diopters.
  • a particular individual may not have the exact same outcome as another 22
  • Devices of lesser radial cross-sectional area are calculated to correct a smaller amount of myopia and devices of greater radial cross-sectional areas are calculated to correct a greater diopteric amount of myopia.
  • FIG. 7(b) demonstrates the change in peripheral corneal volume displacement following strand removal. It can be seen that the radial cross-sectional area circumscribed by the lamellar channel walls 24, 25 in FIG. 7(a) is greater than the radial cross-sectional area circumscribed by the lamellar channel walls 34, 35 in FIG. 7(b). Strand removal from the peripheral cornea thus allows a method of adjusting the anterior corneal curvature following device implantation.
  • the number of strands within the device and the radial cross-sectional size of the individual strands can be selected pre-operatively to minimize the number of strands that needs to be removed to effect a reasonable diopteric change.
  • a strand may have a radial cross-sectional diameter of 0.02 to 1.0 mm in diameter.
  • Formulas can be developed that predict the diopteric change expected following removal of a single strand of a given radial cross-sectional diameter while taking into consideration such factors as initial refractive error, refractive change effected by the particular implant, number of strands in the initial implant, and corneal implant diameter.
  • the radial cross-sectional size of strands is chosen such that removal of a single strand will effect a steepening in corneal curvature by approximately 0.1 to 1.00 diopter.
  • the device consists of three to ten strands 16 of varying diameter and composition.
  • Each strand can vary from 0.02 mm in diameter to 1.0 mm in diameter.
  • the strands may be clear or colored.
  • the strands may have a pre-fabricated loop at one end which would facilitate removal of the strand by using an instrument having a small hook at the operative end with which the loop can be snared, as previously described in this inventor's U.S. Pat. Application No. 08/829,846, filed April 1, 1997.
  • the strand end may have some other configuration such as a rounded or thickened end that would also facilitate grasping the strand.
  • the loop also aids in preventing surrounding rings from being pulled out simultaneously by providing resistance at the open end.
  • the strands may also have a small identifying mark such as a horizontal scratch or notch versus a vertical scratch or notch at a predetermined location so the various marks can be correlated to the actual diameter of the strand. In the event that strand removal is later required, this marking system would identify larger or smaller strands and thus guide the surgeon in the amount of refractive reversal he can expect.
  • a small identifying mark such as a horizontal scratch or notch versus a vertical scratch or notch at a predetermined location
  • the device consisting of an annular collection of strands with several encircling bands is implanted into a circular lamellar channel formed at l to 2/3 corneal depth.
  • a knife is used to make a small midperipheral corneal incision. The surface of the cornea is cut only at this incision.
  • a Suarez spreader or other lamellar dissecting instrument is introduced into the bottom of the incision and a small lamellar channel created.
  • Application of a suction ring may be used to fix the globe while an 8-9 mm outer diameter lamellar channeling tool introduced through the incision into the lamellar channel is rotated to produce an annular channel around the corneal mid-periphery at '/_ to 2/3 corneal depth.
  • the device may be delivered into position by an instrument 40.
  • the instrument is circular in shape and can be inserted into a previously formed annular intrastromal lamellar channel.
  • the circular portion of the instrument to be inserted into the channel is hollow 48.
  • the leading end 42 of the instrument demonstrates its hollow nature.
  • the hollow compartment of the instrument is filled with the strands of the device and the instrument is inserted into the pre-formed annular lamellar channel.
  • FIG. 8(c) shows that the instrument has a conic angle 43 similar to that of the peripheral cornea.
  • FIG. 8(d) illustrates the typical dimensions of the radial cross-section of the instrument which are similar to the dimensions for the device. Referring to FIG.
  • FIG. 10(a) shows the instrument, similar to that previously described in FIG. 8. However, the instrument has a leading wedge segment 60. The wedge segment is attached to the device contained within the body of the instrument.
  • FIG. 11(a) illustrates the instrument 40 with the leading wedge segment 60, completely inserted within the previously formed lamellar intrastromal channel.
  • FIG. 11(b) demonstrates partial removal of the instrument 40.
  • the complete instrument is not illustrated to ease visualization 61.
  • the wedge segment 60 easily permits forward progress but resists backward movement.
  • the wedge segment which is attached to the strands maintains its position. Since the wedge segment is attached to the strands, the strands are removed from the instrument as the instrument is removed from the cornea. Alternatively, the wedge segment may be grasped by a forceps or some other means through the incision 28 while the instrument 40 is being removed. Referring to FIG. 11(c), following implantation of the strands, the wedge segment is detached from the leading end of the strands 62. 25
  • FIG. 12(a) demonstrates a radial cross-section through line 11(b) — 11(b).
  • the instrument 40 can be seen within the lamellar walls 24, 25 of the cornea.
  • the strands 16 can be seen inside the hollow chamber of the instrument.
  • FIG. 12(b) demonstrates a radial cross- section of line 11(c) — 11 (c) after the instrument has been completely remove, leaving the strands of the device in position within the lamellar channel.
  • the device may be pulled into position within the previously formed lamellar channel.
  • the instrument 71 has an annular portion that can be inserted into the previously formed annular channel, a handle portion 72, and a leading end hooked portion 73 to which the device can be attached.
  • the leading end of the instrument may have a hook 73, forcep jaws, or other attachment means whereby the device can be attached and pulled into position.
  • the instrument 71 is inserted into the annular lamellar channel counter-clockwise and the device inserted in a clockwise fashion.
  • the leading end of the instrument 73 is rotated into the annular channel until the leading end of the device 75 can be fixed onto the leading end of the instrument 73.
  • this attachment occurs with the instrument almost completely inserted and the device only partially inserted.
  • the instrument is then rotated in a direction to remove the instrument thus progressively advancing the device into position within the annular channel.
  • the device may also be pulled into position within the annular lamellar channel using magnetic forces.
  • the head of the device has attached a metal segment 80 with smooth surfaces.
  • the metal segment is made of a material, such as iron, that is attracted to a magnet.
  • the device is partially inserted into the pre-formed lamellar channel.
  • a magnet 81 is then used at a point above the cornea anterior to the clip.
  • the magnet 81 is rotated in a circular fashion such that the clip follows the annular lamellar channel and the device 20 is progressively pulled into position. After complete insertion, the head of the device containing the clip is removed from device 83.
  • strand removal 91 from the cornea 13 can be accomplished at the time of surgery with an intraoperative keratoscope to guide the refractive change.
  • Strand removal is accomplished by making an incision 92, either radial or horizontal, into the anterior cornea at a site near the strands. This incision may be made at the initial incision site or at any other site on the cornea anterior to the strands. Preferably, the incision site is made 180 degrees away from the initial incision site at a location 180 degrees away from the two ends of a strand so that the original incision is left undisturbed. The incision is made through the upper lamellar channel wall 24 such that the strands can be accessed.
  • a strand 91 can be removed from the incision site by a forceps type instrument or an instrument with a small hook at the end such as an iris hook.
  • Postoperative adjustments are rendered simple and easy requiring only strand removal and avoid the complications of re-operation concomitant with most kerato-refractive procedures.
  • the decrease in amount of peripheral corneal tissue displaced following removal of strands is important in effecting the refractive adjustment.
  • This postoperative adjustment can compensate for an inadequate preoperative implant choice, for corneal hydration intra-operatively which results in a different corneal curvature after corneal hydration status changes post-operatively, for an unexpected wound healing response in the periphery to the implant, and for later refractive changes caused by unknown factors.
  • This postoperative adjustment is made possible by the implantation into the peripheral corneal stroma several strands which can easily be removed thus modifying the volume of peripheral corneal tissue displaced by the strands and resulting in increased corneal curvature.
  • Strand removal from the peripheral cornea is more easily accomplished than complete removal of a ring that displaces a comparable amount of corneal tissue as the multiple strands. Strand removal also allows a more simple adjustment than complete removal of the ring followed by re-implantation of a smaller or larger ring. Strand removal is also expected to disturb the stromal-implant interface less than complete removal of the whole ring, thus 27
  • Circular cross-sectional strands displace the most corneal tissue relative to its corneal contact and thus for a given peripheral corneal volume displacement change disturbs the surrounding cornea the least.
  • Flat cross-sectional strands have a large area of corneal contact and thus its removal causes maximal disturbance of the surrounding cornea for a slight peripheral corneal volume displacement decrease.
  • a flat strand has a relatively large area of contact between the strand and the corneal tissue relative to the amount of peripheral corneal volume displacement it effects. This large area of contact between the strand and the corneal stroma becomes problematic when an attempt is made to remove the flat strand at a later date after wound healing in the area around the ring has stabilized.
  • an appropriate device varied in strand radial cross-sectional shape, size, composition, number, and length is chosen.
  • the size of the device is chosen such that the range of over-correction or under-correction secondary to individual variability of response to surgery may be comfortably corrected (not requiring removal of all of the strands) by the methods described.
  • the factors described above are chosen prior to insertion of the implant. The more peripherally in the cornea the device is placed, the less the refractive effect. Adjustable devices placed closer to the central cornea can potentially correct up to 20 diopters of myopia. Devices placed at a lesser depth within the corneal stroma are also expected to have a greater refractive effect.
  • this device may be used to correct astigmatism.
  • Curvature variation of the anterior surface of the cornea is responsible for the majority of cases of astigmatism.
  • the light rays converge upon more than one plane and no one principal focus is formed.
  • Astigmatism ordinarily depends on the presence of toroidal instead of spherical curvatures of the refractory surfaces of the eye. It thus becomes obvious that to correct astigmatism certain areas of the cornea must necessarily be corrected to a greater degree than other areas.
  • the strands can be varied in thickness along its circumference with the thicker strand areas displacing a greater amount of peripheral corneal tissue and corresponding to the areas of the cornea having a steeper slope and requiring greater correction.
  • the strands are not necessarily 360 degrees in length.
  • the U.S. Patent, "Adjustable Corneal Arcuate Segments", filed by this author in 1998, is included herein in its entirety by reference. It is anticipated by this author that the various segment shapes and arc lengths described in the "Adjustable Corneal Arcuate Segments" patent can also be applied to the device of the current invention in the treatment of astigmatism, hyperopic astigmatism, myopic astigmatism, and the adjustments thereof.
  • the device volume is adjusted with less disturbance of the surrounding tissue. There is some disturbance of the corneal-strand interface but only in the vicinity of the strand that is removed while the other strands and surrounding cornea is relatively undisturbed. Also, the additional shearing of the cornea caused by re-implanting another complete ring is avoided. In conclusion, a slight decrease in volume of peripheral corneal tissue displaced by the adjustment described is not only easier to perform, but also expected to have a much more predictable effect.
  • This new espoused device allows for the fact that individual tissue response to the calculated correction may not be completely predictable, and permits easy adjustments at the time of surgery and more importantly, at a later date after corneal hydration and would healing responses have stabilized, by simple strand removal from the implanted device. The nature of these adjustments minimally disturb the implant-corneal interface (unlike the explantation of the ICR) and will thus allow a much more predictable adjustment.
  • a hyperopic outcome is very difficult to correct with any of the current kerato-refractive procedures and over-correction of myopia does occur.
  • a hyperopic outcome is relatively easily reversed by ring removal from the implanted device.
  • the surgeon aims for a slight under-correction because of the wish to avoid a hyperopic outcome.
  • the ease with which a hyperopic outcome is adjusted with the device of the present invention enables the surgeon to aim for full correction, thereby obtaining the full benefit of the nomogram, and resulting in a higher percentage of patients with the desired refractive outcome even without a modification of the device.
  • the surgeon may even choose to slightly overcorrect followed by a modification.
  • FIG. 17(a) it can be seen that there are many more patients with an uncorrected visual acuity of 20/20 on the right side (hyperopic, over-corrected) of the graph.
  • the problem is that only 50% of patients achieve an uncorrected visual acuity of 20/20.
  • FIG. 17(b) it becomes obvious that the easiest way to increase the percentage of patients achieving 20/20 is to shift the curve to the right. This means a higher percentage of over-corrected patients but also a much higher percentage achieving uncorrected vision of 20/20.
  • Patients on the left side of the graph can be re-treated for their residual myopia.
  • FIG. 17(c) demonstrates the usefulness of a refractive procedure that can be partially reversed after the initial procedure. Assuming that a refractive procedure can easily be partially reversed after the initial procedure, the curve can safely be shifted to the right. All the patients in FIG. 17(b) who are > 1.0 diopter overcorrected can undergo a partial reversal by simple strand removal. Even if only slightly hyperopic, if the patients become symptomatic, they may choose to undergo a partial reversal. This results in a much narrower distribution of patients and a distribution of patients that surrounds emmetropia.
  • Dr. R. Eiferman in the Journal of Refractive and Corneal Surgery states that "if we can regulate the amount of tissue that is either added to or subtracted from the cornea and control the biological response, we may then be able to optimize refractive surgery".
  • the ideal method to control the biological response is to minimally disturb corneal tissue, thus minimally inciting a wound healing response.
  • the essence of this invention lies in the assumption that individual responses to any kerato-refractive surgical procedures are variable, that even a "perfect" nomogram will not lead to a reliably predictable result in a particular individual, that a simple, safe, and effective technique for corneal curvature adjustment is necessary and that this modification should 32
  • a key feature of this invention lies in the ability of the device in its various embodiments to allow peripheral corneal volume displaced to be modified with ease at the time of implantation but more importantly on multiple occasions thereafter by simple removal of strand material from the implanted device, thus allowing fine-tuning of the refractive outcome.

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Prostheses (AREA)

Abstract

Cette invention se rapporte à un implant cornéen conçu pour être placé dans la cornée chez l'homme, en vue d'une correction de la réfraction, cet implant comprenant: au moins trois brins souples de forme annulaire; et au moins deux bandes entourant les brins pour maintenir ceux-ci à proximité relativement étroite les uns des autres.
PCT/US1999/006923 1998-03-30 1999-03-29 Appareil pour ajuster la courbure de la cornee au moyen d'implants corneens multiples amovibles WO1999049813A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU33719/99A AU3371999A (en) 1998-03-30 1999-03-29 Apparatus for adjusting corneal curvature using multiple removable corneal implants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7993098P 1998-03-30 1998-03-30
US60/079,930 1998-03-30

Publications (1)

Publication Number Publication Date
WO1999049813A1 true WO1999049813A1 (fr) 1999-10-07

Family

ID=22153716

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/006923 WO1999049813A1 (fr) 1998-03-30 1999-03-29 Appareil pour ajuster la courbure de la cornee au moyen d'implants corneens multiples amovibles

Country Status (2)

Country Link
AU (1) AU3371999A (fr)
WO (1) WO1999049813A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000007525A1 (fr) * 1998-08-05 2000-02-17 Keravision, Inc. Implant corneen comportant un insert empechant la migration
EP2164434A4 (fr) * 2007-05-30 2014-01-01 Carneiro Adriano Biondi Monteiro Dispositif pour une transplantation de cornée sans suture
WO2023163468A1 (fr) * 2022-02-22 2023-08-31 재단법인 아산사회복지재단 Échafaudage pour transplantation de cellules endothéliales cornéennes, et son procédé de fabrication
EP4218670A4 (fr) * 2020-09-25 2023-11-22 Paulo Ferrara De Almeida Cunha Dispositif intrastromal à segment double pour corrections d'amétropies sévères
WO2023224173A1 (fr) * 2022-05-18 2023-11-23 유한회사 웰씨 Élément d'insert oculaire et procédé d'insertion d'élément d'insert oculaire

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887846A (en) 1973-05-02 1975-06-03 Berckheim Graf Von Electrodes for air conditioning apparatus
US4452235A (en) 1982-01-04 1984-06-05 Reynolds Alvin E Method for corneal curvature adjustment
US4688570A (en) 1981-03-09 1987-08-25 The Regents Of The University Of California Ophthalmologic surgical instrument
US4815463A (en) 1983-12-21 1989-03-28 Laboratoire Hydron Surgical apparatus for radial keratotomy
US4941093A (en) 1985-09-12 1990-07-10 Summit Technology, Inc. Surface erosion using lasers
US5090955A (en) 1990-07-12 1992-02-25 University Of Miami Gel injection adjustable keratoplasty
WO1994006504A1 (fr) * 1992-09-21 1994-03-31 Keravision Inc. Dispositifs reglables destines au reglage de la courbure de la cornee
US5733334A (en) * 1996-12-09 1998-03-31 Microoptix Method and apparatus for adjusting corneal curvature

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887846A (en) 1973-05-02 1975-06-03 Berckheim Graf Von Electrodes for air conditioning apparatus
US4688570A (en) 1981-03-09 1987-08-25 The Regents Of The University Of California Ophthalmologic surgical instrument
US4452235A (en) 1982-01-04 1984-06-05 Reynolds Alvin E Method for corneal curvature adjustment
US4815463A (en) 1983-12-21 1989-03-28 Laboratoire Hydron Surgical apparatus for radial keratotomy
US4941093A (en) 1985-09-12 1990-07-10 Summit Technology, Inc. Surface erosion using lasers
US5090955A (en) 1990-07-12 1992-02-25 University Of Miami Gel injection adjustable keratoplasty
WO1994006504A1 (fr) * 1992-09-21 1994-03-31 Keravision Inc. Dispositifs reglables destines au reglage de la courbure de la cornee
US5733334A (en) * 1996-12-09 1998-03-31 Microoptix Method and apparatus for adjusting corneal curvature

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000007525A1 (fr) * 1998-08-05 2000-02-17 Keravision, Inc. Implant corneen comportant un insert empechant la migration
EP2164434A4 (fr) * 2007-05-30 2014-01-01 Carneiro Adriano Biondi Monteiro Dispositif pour une transplantation de cornée sans suture
EP4218670A4 (fr) * 2020-09-25 2023-11-22 Paulo Ferrara De Almeida Cunha Dispositif intrastromal à segment double pour corrections d'amétropies sévères
WO2023163468A1 (fr) * 2022-02-22 2023-08-31 재단법인 아산사회복지재단 Échafaudage pour transplantation de cellules endothéliales cornéennes, et son procédé de fabrication
WO2023224173A1 (fr) * 2022-05-18 2023-11-23 유한회사 웰씨 Élément d'insert oculaire et procédé d'insertion d'élément d'insert oculaire

Also Published As

Publication number Publication date
AU3371999A (en) 1999-10-18

Similar Documents

Publication Publication Date Title
US5855604A (en) Method and apparatus for adjusting corneal curvature using a solid filled corneal ring
US6159241A (en) Method and apparatus for adjusting corneal curvature using multiple removable corneal implants
US6066170A (en) Method and apparatus for adjusting corneal curvature
US5876439A (en) Method and appartus for adjusting corneal curvature using a fluid-filled corneal ring
US6206919B1 (en) Method and apparatus to correct refractive errors using adjustable corneal arcuate segments
US6228114B1 (en) Adjustable corneal ring
US11273028B2 (en) Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
US8337550B2 (en) Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
EP2001407B1 (fr) Insert cornéen intrastromal préformé pour anomalies ou dystrophies cornéennes
WO1999062434A1 (fr) Procede et appareil utilisant un cristallin artificiel dans la chambre anterieure
AU730045B2 (en) Method and apparatus for adjusting corneal curvature using corneal ring with removable biocompatible material
WO1999049813A1 (fr) Appareil pour ajuster la courbure de la cornee au moyen d'implants corneens multiples amovibles
WO1999049814A1 (fr) Procede et appareil d'ajustement de la courbure de la cornee
WO1999063912A1 (fr) Procede et appareil d'insertion d'un anneau corneen
AU2015264864A1 (en) Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载